Nevro Corp
NYSE:NVRO
Nevro Corp
NYSE:NVRO
Price:
11.29 USD
1.26%
Market Closed
Updated:
May 5, 2024
Nevro Corp
Operating Income
|
Nevro Corp
Operating Income Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nevro Corp
NYSE:NVRO
|
Operating Income
-$99.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-15%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Nevro Corp's Operating Income?
Operating Income
-99.3m
USD
-99.3m
USD
Based on the financial report for Dec 31, 2023, Nevro Corp's Operating Income amounts to -99.3m USD.
What is Nevro Corp's Operating Income growth rate?
Operating Income CAGR 10Y
-15%
-15%
Over the last year, the Operating Income growth was -1%. The average annual Operating Income growth rates for Nevro Corp have been -16% over the past three years , -19% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
